Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елена Викторовна КравченкоfiledCriticalЕлена Викторовна Кравченко
Priority to UAU201105582UpriorityCriticalpatent/UA65489U/en
Publication of UA65489UpublicationCriticalpatent/UA65489U/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for prevention of development of placenta dysfunction in women of risk group is carried out by medicament treatment. As a hormonotherapy Dufaston is used 20 mg per day, from 8 to 18 week the metabolic therapy is conducted on 10-11 and 15-16 weeks of pregnancy and as therapy which improves uterus and placentar blood circulation, Gingko Biloba is prescribed 40 mg 3 times per day, Erinit 1 tablet 3 times per day, Magne B6 2 tablets 3 times per day, folic acid 1 tablet 2 times per day and vitamin of E 1 capsule 2 times per day during 10-12 days.
UAU201105582U2011-05-042011-05-04method for prevention of development of placenta dYsfunction in women of risk group
UA65489U
(en)